Pharmaceutical Cleanroom News
Get the latest pharmaceutical cleanroom news and updates below. Cleanroom Connect brings you the latest news from around the world, featuring current topics and news in the Pharmaceutical and Biotech industries.
When tissue is damaged, one of the body’s first inflammatory immune-system responders are macrophages, cells which are commonly thought of as “construction workers” that clear away damaged tissue debris and initiate repair. However, prolonged inflammation promotes the progression of many diseases, including obesity.
With an aim to grow and further establish their international presence in pharmaceutical manufacturing, Wockhardt inaugurated a ‘state-of-the-art’ sterile dry powder injection cleanroom manufacturing facility for the production and packaging of sterile dry powder injection in Dubai. On approval of the new drug by US FDA, this manufacturing facility will be commissioned for commercial production.
Genomma Lab will be able to focus on lowering its production costs, and thus offering more affordable medicines and products across the region.”, said Mr Maximo Juda, CEO of the Company. “Both multi-lateral institutions will not only provide long-term financing but also key strategic advice given their extensive industry expertise in pharma and environmental matters”, added Mr. Antonio Zamora Galland, CFO of Genomma Lab
The Atropine Autoinjector initially received Emergency Use Authorization from the FDA in April 2017. Atropine is one of the most commonly used drugs for the treatment of chemical nerve agent poisoning. With the approved Atropine Autoinjector, U.S. troops can rapidly inject atropine into the thigh muscle following nerve agent exposure.
Almac has manufactured multiple High Throughput batches of neoantigen derived peptides –branded by Almac as NeoPeptides™ – for compassionate use treatments, and for P-I clinical trials, from its Edinburgh facility. Over the course of the past ten months the facility has been upgraded and segregated to enable GMP supply.
Biosensors are devices that can detect biological molecules in air, water, or blood. They are widely used in drug development, medical diagnostics, and biological research. The growing need for continuous, real-time monitoring of biomarkers in diseases like diabetes is currently driving efforts to develop efficient and portable biosensor devices.
The Brock team’s latest technology builds on an earlier version of the microscopic robot — called the three-dimensional DNA nanomachine — they created in 2016 to detect diseases in a blood sample within 30 minutes.
The creation of artificial embryos has moved a step forward after an international team of researchers used mouse stem cells to produce artificial embryo-like structures capable of ‘gastrulation’, a key step in the life of any embryo.
Scientists at the Mainz University Medical Center and the Max Planck Institute for Polymer Research (MPI-P) have developed a new method to enable miniature drug-filled nanocarriers to dock on to immune cells, which in turn attack tumors.
The dragonfly larva is the only insect that uses jet propulsion to move and the only arthropod known to use reciprocal jetting—inhaling and exhaling through the same orifice—for underwater breathing,” says Roh, the lead author of a paper on the larval jets that was published online by the journal Bioinspiration & Biomimeticson May 30.
the manufacturing facility was designed to achieve Leadership in Energy and Environmental Design (LEED) certification. Moderna is limiting energy use with advanced energy metering, LED lighting, and systems designed to reduce water usage by up to 25%.
Lilly Diabetes Solution Center will assist people who need help paying for their insulin – such as those with lower incomes, the uninsured, and people in the deductible phase of their high-deductible insurance plans, Eli Lilly and Company (NYSE: LLY) announced today. A customized suite of solutions for all Lilly insulins, including for Humalog® (insulin lispro), will be used by helpline operators to find answers that best fit the personal circumstances of patients.
Pharmaceutical Cleanroom News and Advancements
The Pharmaceutical Cleanroom Industry or medicine industry is the commercial industry that discovers, develops, produces, and markets drugs or pharmaceuticals for various uses and formations of medicines and medications. The pharmaceutical cleanroom industry produces the controlled aseptic cleanroom environments where by the pharmaceutical products are created and packaged. Pharmaceutical companies create a various array of products for different applications.
The primary developments of Pharmaceutical companies are generic medications, branded pharmaceuticals and medical devices. The pharmaceutical companies are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy and marketing of drugs. Cleanroom Connect provides the latest Pharmaceutical Cleanroom News from various pharmaceutical and biopharma industries. Subscribe today to receive pharmaceutical and biopharmaceutical news and updates directly to your mailbox.
The Pharmaceutical Cleanroom Industry is a booming industry, and production has been growing exponentially over the past few decades as innovations in the medical field have taken off. This increasing production has also led to increasing demands for safety features installed in industrial pharmaceutical manufacturing plants and storage areas. These safety procedures ensure the health of employees as well as the safe preservation of products that are stored for later use by consumers.